Impact of postoperative prostate-specific antigen disease recurrence and the use of salvage therapy on the risk of death-Reference-Cited by-同舟云学术

Impact of postoperative prostate-specific antigen disease recurrence and the use of salvage therapy on the risk of death

Published:2010-04-15 Issue:8 Volume:116 Page:1887-1892
ISSN:0008-543X
Container-title:Cancer
language:en
Short-container-title:Cancer

Author:

Choueiri Toni K.,Chen Ming-Hui,D'Amico Anthony V.,Sun Leon,Nguyen Paul L.,Hayes Julia H.,Robertson Cary N.,Walther Philip J.,Polascik Thomas J.,Albala David M.,Moul Judd W.

Publisher

Wiley

Subject

Cancer Research,Oncology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/cncr.25013/fullpdf

Reference18 articles.

1. Rising PSA in nonmetastatic prostate cancer;Moul;Oncology (Williston Park).,2007

2. Defining biochemical recurrence of prostate cancer after radical prostatectomy: a proposal for a standardized definition;Stephenson;J Clin Oncol.,2006

3. Surrogate end point for prostate cancer-specific mortality after radical prostatectomy or radiation therapy;D'Amico;J Natl Cancer Inst.,2003

4. Risk of prostate cancer-specific mortality following biochemical recurrence after radical prostatectomy;Freedland;JAMA.,2005

5. Preoperative PSA velocity and the risk of death from prostate cancer after radical prostatectomy;D'Amico;N Engl J Med.,2004

Cited by 33 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Salvage therapies for biochemical recurrence after definitive local treatment: a systematic review, meta-analysis, and network meta-analysis;Prostate Cancer and Prostatic Diseases;2024-09-13

2. False-positive/false-negative findings: the value of PSMA-PET/CT in the staging of patients with prostate cancer;Journal für Urologie und Urogynäkologie/Österreich;2023-08-17

3. Disease Recurrence after Radical Prostatectomy;Salvage Therapy for Prostate Cancer;2020-11-24

4. The Potential Role for Immunotherapy in Biochemically Recurrent Prostate Cancer;Urologic Clinics of North America;2020-11

5. Optimal PSA Threshold for Androgen-Deprivation Therapy in Patients with Prostate Cancer following Radical Prostatectomy and Adjuvant Radiation Therapy;Yonsei Medical Journal;2020